Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2A6 | P11509 | 2/20 | 0.40 |
| ▸ | PRKCI | P41743 | 1/20 | 0.39 |
| ▸ | BRD4 | O60885 | 1/20 | 0.37 |
| ▸ | TAF1 | P21675 | 1/20 | 0.37 |
| ▸ | BRPF1 | P55201 | 1/20 | 0.37 |
| ▸ | CREBBP | Q92793 | 1/20 | 0.37 |
| ▸ | CECR2 | Q9BXF3 | 1/20 | 0.37 |
| ▸ | BRD9 | Q9H8M2 | 1/20 | 0.37 |
| ▸ | PIK3CB | P42338 | 1/20 | 0.35 |
| ▸ | CDK4 | P11802 | 8/20 | 0.35 |
| ▸ | CCND1 | P24385 | 8/20 | 0.35 |
| ▸ | CCNE2 | O96020 | 6/20 | 0.35 |
| ▸ | CCNE1 | P24864 | 6/20 | 0.35 |
| ▸ | CDK2 | P24941 | 6/20 | 0.35 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | APOBEC3A | P31941 | 1/20 | 0.33 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.33 |
| ▸ | PRKACA | P17612 | 2/20 | 0.33 |
| ▸ | PRKACG | P22612 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12278805 | 0.84 | CDK4 (0.38) | CYP2A6PRKCIPIK3CBCDK4CCND1 | |
| SCHEMBL18876190 | 0.80 | CYP2A6 (0.37) | CYP2A6PRKCIBRD4TAF1BRPF1 | |
| SCHEMBL15450901 | 0.77 | KDM4E (0.33) | CYP2A6PRKCICDK4CCND1CCNE2 | |
| SCHEMBL24255194 | 0.77 | LMNA (0.42) | CYP2A6PRKCIPIK3CBCDK4CCND1 | |
| SCHEMBL31057884 | 0.75 | CDK4 (0.35) | CYP2A6CDK4CCND1CCNE2CCNE1 | |
| SCHEMBL594433 | 0.75 | CDK4 (0.36) | CYP2A6CDK4CCND1CCNE2CCNE1 | |
| SCHEMBL23059066 | 0.75 | CDK4 (0.34) | CYP2A6PRKCICDK4CCND1CCNE2 | |
| SCHEMBL13836115 | 0.75 | PSMD14 (0.37) | PRKCICDK4CCND1CCNE2CCNE1 | |
| SCHEMBL4387353 | 0.73 | PRKCI (0.39) | PRKCIPIK3CB | |
| SCHEMBL2052186 | 0.73 | CYP1A2 (0.38) | CDK2KDM4EAPOBEC3G |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230337525-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2023-10-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230337525-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OCIAD1, OCIAD2, OXER1 | CYP2A6 1536/4885PRKCI 3910/4885BRD4 358/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.